IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i3p1286-d490736.html
   My bibliography  Save this article

Increased Alopecia Areata Risk in Children with Attention-Deficit/Hyperactivity Disorder and the Impact of Methylphenidate Use: A Nationwide Population-Based Cohort Study

Author

Listed:
  • Hsing-Ying Ho

    (Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan
    Department of Psychology, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan
    Hsing-Ying Ho and Chih-Kai Wong contributed equally to this work.)

  • Chih-Kai Wong

    (Department of Dermatology, MacKay Memorial Hospital, Taipei 10449, Taiwan
    Hsing-Ying Ho and Chih-Kai Wong contributed equally to this work.)

  • Szu-Yuan Wu

    (Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan
    Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan
    Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 26546, Taiwan
    Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 26546, Taiwan)

  • Ray C. Hsiao

    (Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine and Children’s Hospital, Seattle, WA 98105, USA)

  • Yi-Lung Chen

    (Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan
    Department of Psychology, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan)

  • Cheng-Fang Yen

    (Department of Psychiatry, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan
    Department of Psychiatry, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan)

Abstract

Alopecia areata (AA) is an autoimmune disease that causes sudden hair loss. Although few studies have reported the association between AA and attention-deficit/hyperactivity disorder (ADHD), the impact of methylphenidate (MPH) on AA has not been examined. This study examined whether AA risk is higher in children with ADHD than in those without ADHD as well as the impact of MPH use on AA risk in children with ADHD. From the Taiwan Maternal and Child Health Database, we enrolled all 1,750,456 newborns from 2004 to 2017 in Taiwan. Of them, 90,016 children received a diagnosis of ADHD whereas the remaining 1,660,440 did not. To compare AA risk in ADHD and the impact of MPH treatment on it, multiple Cox regression with adjustments for covariates (i.e., age, sex, and psychiatric comorbidities) was performed. The results indicated that 88 (0.098%) children with ADHD and 1191 (0.072%) children without ADHD had AA. Nevertheless, after adjustment for the covariates, AA risk was higher in children with ADHD than in those without ADHD (adjusted hazard ratio [aHR]: 1.30, 95% confidence interval [CI]: 1.04–1.64). Our data indicated a considerable reduction in AA risk (aHR: 0.64) among children with ADHD who received MPH than among those who did not receive MPH; however, this difference was nonsignificant, indicated by a wide 95% CI (0.32–1.25). In conclusion, ADHD and AA may share some underlying mechanisms.

Suggested Citation

  • Hsing-Ying Ho & Chih-Kai Wong & Szu-Yuan Wu & Ray C. Hsiao & Yi-Lung Chen & Cheng-Fang Yen, 2021. "Increased Alopecia Areata Risk in Children with Attention-Deficit/Hyperactivity Disorder and the Impact of Methylphenidate Use: A Nationwide Population-Based Cohort Study," IJERPH, MDPI, vol. 18(3), pages 1-7, February.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:3:p:1286-:d:490736
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/3/1286/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/3/1286/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:3:p:1286-:d:490736. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.